|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"jp liou"
Showing items 1-25 of 32 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
| 臺北醫學大學 |
2014 |
Antimitotic and vascular disrupting agents: 2-hydroxy-3,4,5-trimethoxybenzophenones
|
CY, Chang;HY, Chuang;HY, Lee;TK, Yeh;CC, Kuo;CY, Chang;JY, Chang;JP, Liou |
| 臺北醫學大學 |
2014 |
Curcumin Suppress Cardiac Fibroblasts Activitiesby Regulating Proliferation, Migration, and the Extracellular Matrix
|
CC, Chung;YH, Kao;JP, Liou;YJ, Chen |
| 臺北醫學大學 |
2014 |
Denbinobin upregulates miR-146a expression and attenuates IL-1β-induced upregulation of ICAM-1 and VCAM-1 expressions in osteoarthritis fibroblast-like synoviocytes
|
CR, Yang;KS, Shih;JP, Liou;YW, Wu;IN, Hsieh;HY, Lee;TC, Lin;JH, Wang |
| 臺北醫學大學 |
2014 |
In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells
|
AC, Tsai;HC, Pai;CY, Wang;JP, Liou;CM, Teng;JC, Wang;SL, Pan |
| 臺北醫學大學 |
2014 |
Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity
|
Mehndiratta, S;YL, Hsieh;YM, Liu;AW, Wang;HY, Lee;LY, Liang;Kumar, S;CM, Teng;CR*, Yang;JP*, Liou |
| 臺北醫學大學 |
2014 |
K20E, an oxidative-coupling compound of methyl caffeate, exhibits anti-angiogenic activities through down-regulations of VEGF and VEGF receptor-2
|
HY, Lee;LT, Wang;YH, Li;SL, Pan;YL, Chen;CM, Teng;JP, Liou |
| 臺北醫學大學 |
2014 |
Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib
|
AC, Tsai;CY, Wang;JP, Liou;HC, Pai;CJ, Hsiao;JY, Chang;JC, Wang;CM, Teng;SL, Pan |
| 臺北醫學大學 |
2014 |
Preclinical anti-arthritic study and pharmacokinetic properties of a potent histone deacetylase inhibitor MPT0G009
|
IN, Hsieh;JP, Liou;HY, Lee;MJ, Lai;YH, Li;CR, Yang |
| 臺北醫學大學 |
2014 |
Synergistic Interaction between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer Cells In Vitro and In Vivo
|
CH, Chen;MC, Chen;JC, Wang;AC, Tsai;CS, Chen;JP*, Liou;SL*, Pan;CM*, Teng |
| 臺北醫學大學 |
2014 |
Tubulin inhibitors: a patent review
|
YM, Liu;HL, Chen;HY, Lee;JP, Liou |
| 臺北醫學大學 |
2014 |
Indolyl or Indolinyl hydroxamate compounds
|
CS, Chen;JP, Liou;HJ, Liu;KS, Hung;PW, Shan;WT, Chiu;CM, Teng |
| 臺北醫學大學 |
2014 |
Synergistic Interaction between the HDAC Inhibitor, MPT0E028, and Sorafenib in Liver Cancer Cells In Vitro and In Vivo
|
Chen, CH;Chen, MC;Wang, JC;Tsai, AC;Chen, CS;JP*, Liou;SL*, Pan;CM*, Teng |
| 臺北醫學大學 |
2014 |
Azaindolylsulfonamides, with a More Selective Inhibitory Effect on Histone Deacetylase 6 Activity, Exhibit Antitumor Activity in Colorectal Cancer HCT116 Cells
|
HY, Lee;AC, Tsai;MC, Chen;PJ, Shen;YC, Cheng;CC, Kuo;SL, Pan;YM, Liu;JF, Liu;TK, Yeh;JC, Wang;CY, Chang;JY, Chang;JP, Liou |
| 臺北醫學大學 |
2014 |
A novel class I HDAC inhibitor, MPT0G030, induces cell apoptosis and differentiation in human colorectal cancer cells via HDAC1/PKCδ and E-cadherin
|
LT, Wang;JP, Liou;YH, Li;YM, Liu;SL, Pan;CM, Teng |
| 臺北醫學大學 |
2014 |
Intermediary Metabolite Precursor Dimethyl-2-Ketoglutarate Stabilizes Hypoxia-Inducible Factor-1α by Inhibiting Prolyl-4-Hydroxylase PHD2
|
Hou, P;CY, Kuo;CT, Cheng;JP, Liou;DK, Ann;Chen, Q |
| 臺北醫學大學 |
2013 |
Evaluation of the safety and efficacy of warfarin in Taiwanese patients
|
LN, Kuo;JP, Liou;HY, Chen;YC, Chiang;MT, Wu |
| 臺北醫學大學 |
2013 |
1-Arylsulfonyl-5-(N-hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors
|
HY, Lee;CR, Yang;MJ, Lai;HL, Huang;YL, Hsieh;YM, Liu;YH, Yeh TK. Li;Mehndiratta, S;CM, Teng;JP*, Liou |
| 臺北醫學大學 |
2013 |
MPT0B098, a novel microtubule inhibitor that destabilizes the hypoxia-inducible factor-1α mRNA through decreasing nuclear-cytoplasmic translocation of RNA-binding protein HuR
|
YC, Cheng;JP, Liou;CC, Kuo;WY, Lai;KH, Shih;CY, Chang;WY, Pan;JT, Tseng;JY, Chang |
| 臺北醫學大學 |
2013 |
Histone deacetylase inhibition improved cardiac functions with direct antifibrotic activity in heart failure
|
YH, Kao;JP, Liou;CC, Chung;GS, Lien;CC, Kuo;SA, Chen;YJ, Chen |
| 臺北醫學大學 |
2013 |
1-Arylsulfonyl-5-(N-hydroxyacrylamide)indolines Histone Deacetylase Inhibitors Are Potent Cytokine Release Suppressors
|
Lee, HY;Yang, CR;Lai, MJ;Huang, HL;Hsieh, YL;Liu, YM;Yeh TK.Li, YH;Mehndiratta, S;Teng, CM;JP*, Liou |
| 臺北醫學大學 |
2013 |
Furanylazaindoles: Potent Anticancer Agents in Vitro and in Vivo
|
Lee, HY;Pan, SL;Su, MC;Liu, YM;Kuo, CC;Chang, YT;Wu, JS;Nien, CY;Mehndiratta, S;Chang, CY;Wu, SY;Lai, MJ;JY*, Chang;JP*, Liou |
| 臺北醫學大學 |
2013 |
A novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathway
|
NJ, Chiang;CI, Lin;JP, Liou;CC, Kuo;CY, Chang;LT, Chen;JY, Chang |
| 臺北醫學大學 |
2013 |
Furanylazaindoles: Potent Anticancer Agents in Vitro and in Vivo
|
HY, Lee;SL, Pan;MC, Su;YM, Liu;CC, Kuo;YT, Chang;JS, Wu;CY, Nien;Mehndiratta, S;CY, Chang;SY, Wu;MJ, Lai;JY*, Chang;JP*, Liou |
| 臺北醫學大學 |
2012 |
ARYL SUBSTITUTED SULFONAMIDE COMPOUNDS AND THEIR USE AS ANTICANCER AGENTS
|
JP, Liou;JY, Chang |
| 臺北醫學大學 |
2012 |
Anti-Arthritic Effects of Magnolol in Human Interleukin 1b-Stimulated Fibroblast-Like Synoviocytes and in a Rat Arthritis Model
|
JH, Wang;KS, Shih;JP, Liou;YM, Wu;ASY, Chang;KL, Wang;CL, Tsai;CR, Yang |
Showing items 1-25 of 32 (2 Page(s) Totally)
1 2 > >>
View [10|25|50] records per page
|
